Special Advisor on Policy & Strategy to the Director | Director, James A. Baker III Policy Leadership Program
Nonresident Fellow in Drug Policy
Nonresident Fellow in Drug Policy
Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.
Last August, the Department of Health and Human Services recommended the rescheduling of marijuana from Schedule I to Schedule III, which the Drug Enforcement Administration is currently considering. If enacted, the change will have a significant effect on how states enforce drug laws.
Discussants:
This conversation was recorded on Jan. 25, 2024.
Baker Briefing is a podcast that tackles the most critical foreign and domestic policy issues of the day in conversations with experts at the Baker Institute. Hosted by the Honorable David M. Satterfield, director of the Baker Institute, new episodes are released weekly.
Each episode of Baker Briefing is recorded in front of a live audience at Rice University in Houston, Texas. You can attend live recordings by joining the Baker Roundtable, the Baker Institute’s membership forum.
This material may be quoted or reproduced without prior permission, provided appropriate credit is given to the author and Rice University’s Baker Institute for Public Policy. The views expressed herein are those of the individual author(s), and do not necessarily represent the views of Rice University’s Baker Institute for Public Policy.
